We also obtained similar results in a colitis mouse model, wherein miR-206 increased the severity of DSS-induced colitis, measured as enhanced bodyweight loss, DAI score, colon shrinkage, and MPO activity, whereas miR-206-antagomir treatment partially ameliorated these effects. Here, MPO is linked to colitis.